Radiopharmaceuticals for brain imaging (Q40566753)

21 September 2017

1 reference

title

Radiopharmaceuticals for brain imaging (English)

1 reference

21 September 2017

Saha GB

1

1 reference

PubMed ID

7817203

21 September 2017

MacIntyre WJ

series ordinal

2

1 reference

PubMed ID

7817203

21 September 2017

Go RT

series ordinal

3

1 reference

21 September 2017

1 October 1994

1 reference

Seminars in Nuclear Medicine

21 September 2017

1 reference

21 September 2017

24

1 reference

21 September 2017

4

1 reference

21 September 2017

324-349

1 reference

Basic aspects of brain tumor localization by radioactive substances. A review of current concepts

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Distribution and excretion of technetium in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

An analysis of technetium (99mTcO4-) kinetics: the effect of perchlorate and iodide pretreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Technetium-99m DTPA: A New Radiopharmaceutical for Brain and Kidney Scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Diagnosis of cerebral lesions by Thallium 201

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Diagnosis of cerebral metastases by thallium 201

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Adjunctive brain scanning with 67 Ga in metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Brain Scintigraphy with99mTc Pertechnetate,99mTc Polyphosphate, and67Ga Citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

131I-labelled N-isopropyl-p-Iodoamphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

[123I]iodoamphetamine SPECT imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Predictive value of perfusion defect size using N-isopropyl-(I-123)-p-iodoamphetamine emission tomography in acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Pathophysiologic study of chronic infarcts with I-123 isopropyl iodo-amphetamine (IMP): the importance of periinfarct area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Utility of late N-isopropyl-p-(iodine-123)-iodoamphetamine brain distribution in predicting outcome following cerebral infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Single photon emission computed tomography (SPECT) using N-isopropyl-p-(123I) iodoamphetamine (IMP) in the evaluation of patients with epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

A neutral lipophilic complex of 99mTc with a multidentate amine oxime.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Intracellular localization of 99Tcm-d,l-HMPAO and 201Tl-DDC in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Quantitative measurements of cerebral blood flow using SPECT and [99mTc]-d,l-HM-PAO compared to xenon-133.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Tc99m HM-PAO single photon emission computed tomography in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Patterns of postictal cerebral blood flow in temporal lobe epilepsy: qualitative and quantitative analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

"Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

SPECT with [99mTc]-d,l-hexamethyl-propylene amine oxime (HM-PAO) compared with regional cerebral blood flow measured by PET: effects of linearization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

A single-photon emission computed tomography study of hypoperfusion after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Postoperative assessment of cerebral blood flow in subarachnoid haemorrhage by means of 99mTc-HMPAO tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

The chemistry of 99mTc-labeled radiopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Investigation of cerebral blood-flow in hypertension, using radioactive-xenon inhalation and extracranial recording.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Measurement of regional blood flow in cerebral cortex of man through intact skull.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Regional cerebral blood flow in stroke by 133Xenon inhalation and emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

External imaging of cerebral muscarinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Synthesis and evaluation of radioiodinated derivatives of 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(4-iodophenyl)-alpha- phenylacetate as potential radiopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Synthesis and resolution of (.+-.)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Diagnostic imaging of human neuroblastoma with radiolabeled antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography with 68Ga-EDTA compared with transmission computed tomography in the evaluation of brain infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of 82Rb: the effect of dexamethasone and whole-brain radiation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Quantitative Measurement of Blood—Brain Barrier Permeability Using Rubidium-82 and Positron Emission Tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Quantitative measurement of local cerebral blood flow in humans by positron computed tomography and 15O-water

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Evaluation of regional differences of tracer appearance time in cerebral tissues using [15O] water and dynamic positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

18F-labeled lower fluoroalkanes; reactor-produced gaseous physiological tracers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Quantitation of local cerebral blood flow and partition coefficient without arterial sampling: theory and validation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Determination of regional cerebral blood flow in patients with cerebral infarction. Use of fluoromethane labeled with fluorine 18 and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Cerebral perfusion reserve indexes determined by fluoromethane positron emission scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Cerebral blood volume measured with inhaled C15O and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron imaging of cerebral blood flow during continuous inhalation of C15O2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Measurement of regional cerebral blood flow with positron emission tomography: a comparison of [15O]water to [11C]butanol with distributed-parameter and compartmental models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Synthesis of 15O-labeled butanol via organoborane chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Measurement of human cerebral blood flow with [15O]butanol and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Mapping of functional activity in brain with 18F-fluoro-deoxyglucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

FDG-PET in Pediatric Posterior Fossa Brain Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography in the detection of malignant degeneration of low-grade gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Prediction of survival in glioma patients by means of positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography in patients with glioma. A predictor of prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Brain metastases from non-central nervous system tumors: evaluation with PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Depressed cerebellar glucose metabolism in supratentorial tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

[18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Patterns of cerebral glucose metabolism in patients with partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Electrocorticographic confirmation of focal positron emission tomographic abnormalities in children with intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Comparison of PET measurements of cerebral blood flow and glucose metabolism for the localization of human epileptic foci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

The normal pituitary examined with positron emission tomography and (methyl-11C)-L-methionine and (methyl-11C)-D-methionine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Striatal 18F-dopa uptake: absence of an aging effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

18F‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Dopamine visualized in the basal ganglia of living man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Striatal dopamine distribution in parkinsonian patients during life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Imaging dopamine receptors in the human brain by positron tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Radiosynthesis of an opiate receptor binding radiotracer: [11C]carfentanil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Synthesis of ethyl 8-fluoro-5,6-dihydro5- [11C]methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): A specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Regional specific binding of [11C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980022-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-2998(05)80022-4

1 reference

21 September 2017

1 reference

PubMed ID

7817203